InvestorsHub Logo

concapk

09/02/19 7:08 PM

#212234 RE: north40000 #212233

NORTH40000

I agree with you 100%.....I have read the patents only.... I have already stated that how the patents were reviewed by USPTO, all the meetings with FDA, etc. was not under my purview.... I stated that the judge would make the final rulings....

I was only summarizing the motion presented to the court by the GENERICS...on 08-30-2019

concapk

09/02/19 7:11 PM

#212236 RE: north40000 #212233

Was trying to keep this board informed, so that they may make informed decisions going forward !!!

MateoPaisa

09/02/19 7:37 PM

#212239 RE: north40000 #212233

But that’s the MO of the folks on this board. Throw a bunch of words at them and they’ll make those words absolutely unrecognizable based on absolutely nothing.

flubber

09/02/19 11:39 PM

#212247 RE: north40000 #212233

I agree with North's synopsis of the patent trial issue.

My only concern is the judge. I have no idea of whom the judge is and his/hers previous rulings or dispositions. Just reading the outcome of the recent Amgen patent suit, a jury had a verdict and then the judge decided to overturn it.

In any situation as this, what is the 'pre-disposition' of the judge, if any? Does he/she follow strict interpretation of the law and facts as they are presented, or would he/she have tendency to have a predetermined outcome and mold the facts to fit the final opinion?

To whit...
-Does the judge feel that denying the DS companies their claims harm more companies in the DS industry as compared to little old AMRN?
-Will the judge feel that if the DS companies can market a drug that is an equivalent to Vascepa, the judge ruling in favor of DS would be getting a beneficial drug being produced by more companies at more competitive pricing levels, and therefore reaching more potential patients??
-Does the judge just go back into chambers and flip a coin to arrive at a decision?

I don't think any of the above are valid arguments or scenarios, but I am not the judge.

I think AMRN has a strong case, but again, it will be ONE PERSON that makes the final decision. I like AMRN's odds, but it is not a 100% given of a victory.

Just my 2-cents opinion. The overturn of a jury verdict by the judge in the Amgen case has given me a jaded opinion of the judiciary system.

Cheers!
Flubber